Disposition of 7 shares by Yen Kristen of Soleno Therapeutics at 48.3 subject to Rule 16b-3
SLNO Stock | USD 47.35 0.57 1.19% |
About 66% of Soleno Therapeutics' investor base is looking to short. The analysis of the overall investor sentiment regarding Soleno Therapeutics suggests that many traders are alarmed. Soleno Therapeutics' investing sentiment overview a quick insight into current market opportunities from investing in Soleno Therapeutics. Many technical investors use Soleno Therapeutics stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Soleno |
Filed transaction by Soleno Therapeutics Officer See Remarks. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3
Read at macroaxis.com
Cash Flow Correlation
Soleno Therapeutics' cash-flow correlation analysis can be used to evaluate the unsystematic risk during the given period. It also helps investors identify the Soleno Therapeutics' relationships between the major components of the statement of changes in financial position and other commonly used cash-related accounts. When such correlations are discovered, they may help managers and analysts to enhance performance or determine appealing investment opportunities.Click cells to compare fundamentals
Soleno Therapeutics Investor Sentiment by Other News Outlets
Investor sentiment, mood or attitude towards Soleno Therapeutics can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Soleno Therapeutics Fundamental Analysis
We analyze Soleno Therapeutics' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Soleno Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Soleno Therapeutics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Cash Flow From Operations
Cash Flow From Operations Comparative Analysis
Soleno Therapeutics is currently under evaluation in cash flow from operations category among its peers. Operating Cash Flow reveals the quality of a company's reported earnings and is calculated by deducting company's income taxes from earnings before interest, taxes, and depreciation (EBITDA). In other words, Operating Cash Flow refers to the amount of cash a firm generates from the sales or products or from rendering services. Operating Cash Flow typically excludes costs associated with long-term investments or investment in marketable securities and is usually used by investors or analysts to check on the quality of a company's earnings.
Soleno Therapeutics Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Soleno Therapeutics stock to make a market-neutral strategy. Peer analysis of Soleno Therapeutics could also be used in its relative valuation, which is a method of valuing Soleno Therapeutics by comparing valuation metrics with similar companies.
Peers
Soleno Therapeutics Related Equities
XFOR | X4 Pharmaceuticals | 26.42 | ||||
BPTH | Bio Path | 15.62 | ||||
INZY | Inozyme Pharma | 9.56 | ||||
LYRA | Lyra Therapeutics | 5.00 | ||||
ALRN | Aileron Therapeutics | 0.94 | ||||
PULM | Pulmatrix | 0.17 | ||||
CAPR | Capricor Therapeutics | 1.39 | ||||
BOLT | Bolt Biotherapeutics | 1.72 | ||||
ANNX | Annexon | 1.81 | ||||
DAWN | Day One | 1.86 | ||||
ABOS | Acumen Pharmaceuticals | 3.56 | ||||
BNTC | Benitec Biopharma | 3.61 | ||||
MBRX | Moleculin Biotech | 10.47 | ||||
AKTX | Akari Therapeutics | 14.53 |
Check out Soleno Therapeutics Hype Analysis, Soleno Therapeutics Correlation and Soleno Therapeutics Performance. To learn how to invest in Soleno Stock, please use our How to Invest in Soleno Therapeutics guide.You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Soleno Therapeutics. If investors know Soleno will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Soleno Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.79) | Return On Assets (0.48) | Return On Equity (0.91) |
The market value of Soleno Therapeutics is measured differently than its book value, which is the value of Soleno that is recorded on the company's balance sheet. Investors also form their own opinion of Soleno Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Soleno Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Soleno Therapeutics' market value can be influenced by many factors that don't directly affect Soleno Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Soleno Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Soleno Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Soleno Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.